Uncategorized
Half-dose verteporfin PDT increases visual acuity, reduces recurrence in central serous chorioretinopathy
COLORADO SPRINGS, Colo. — Photodynamic therapy with half-dose verteporfin significantly increased visual acuity in eyes with central serous chorioretinopathy compared with that in untreated controls, according to a study presented here.Furthermore, recurrence was significantly less likely to occur in treated patients during the follow-up (P < .001), Timothy Y.Y. Lai, MD, said in a presentation of his thesis paper to the American Ophthalmological Society.